Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc. | Director | Common Stock | 1.75M | $65.2M | $37.26 | Jul 13, 2023 | Indirect |
Apogee Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10.4K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APGE | Apogee Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
APGE | Apogee Therapeutics, Inc. | Jul 13, 2023 | 2 | $29.8M | 4 | Jul 17, 2023 | Director |
APGE | Apogee Therapeutics, Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | Director |